article thumbnail

EMA unveils first projects as data partners join DARWIN EU project

pharmaphorum

Two years ago, the EMA proposed a set of recommendations to unlock the potential of big data for public health, headlined by the creation of a platform to access and analyse healthcare data from across the bloc. With the first data partners on board, the regulator can now move ahead with the start of its first studies.

article thumbnail

Artificial intelligence could be new blueprint for precision drug discovery

The Pharma Data

The study findings could measurably change how researchers sift through big data to find meaningful information with significant benefit to patients, the pharmaceutical industry and the nation’s health care systems. have access to unlimited amounts of ‘big data’ and better tools than ever to analyze such data. .

Drugs 52